Safety and tolerability study of AZD4831 in patients with heart failure.

Trial Identifier: D6580C00003
Sponsor: AstraZeneca
NCTID:: NCT03756285
Start Date: December 2018
Primary Completion Date: May 2020
Study Completion Date: May 2020
Condition: Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version
Danish Translation
Dutch Translation
Finnish Translation
Swedish Translation

Trial Locations

Country Location
Denmark Aarhus N, Denmark, 8200
Denmark Herlev, Denmark, 2730
Denmark Hvidovre, Denmark, 2650
Denmark Odense C, Denmark, 5000
Finland Turku, Finland, 20520
Netherlands DEVENTER, Netherlands, 7416 SE
Netherlands DORDRECHT, Netherlands, 3318 AT
Netherlands Groningen, Netherlands, 9713 GZ
Sweden Göteborg, Sweden, 41345
Sweden Lund, Sweden, 22242
Sweden Stockholm, Sweden, 171 76
United States of America, IL Chicago, IL, United States of America, 60611
United States of America, MA Boston, MA, United States of America, 02115